Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Value investing offers a powerful approach for beginners. Discover the fundamentals and start making informed investment choices.
19,945 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A quiet strategic shift could power ELF's growth without fanfare. This article breaks down what the move is, why it m...
A private equity veteran, famed for saving Arby’s, now champions a $2.7 billion bid for Pizza Hut. The deal splits be...
SpaceX has pulled back from its recent peak, dropping around 18%. This article explains why this move isn’t a reason ...
In volatile markets, pulling back can create buying opportunities. This article highlights three growth stocks to buy...
Wall Street is split on two big AI chips players: Intel and Marvell. One stock is riding optimism about data-center d...
Apple accelerates its cash-return program with a fresh buyback authorization and a dividend bump, underscoring a disc...
A rally in AeroVironment shares has investors wondering what sparked the move. This guide breaks down the factors beh...
Salesforce enters its earnings print amid a mood swing for cloud software, with AI investments weighing on profits an...
Anthropic’s dispute with the Pentagon over ethical uses triggers a contract cancellation and a supply chain risk desi...
Autonomous AI agents are moving beyond chatbots to do complex tasks. This article explains why the agentic market cou...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...